immunotherapies - commercial

IVIG

IVIG is an antibody-based product that contains the spectrum of antibodies normally present in healthy adult human plasma. It can be used to provide ongoing treatment for primary and secondary immune deficiencies as well as replacement therapy as in Idiopathic Thrombocytopenic Purpura (ITP) by providing a broad selection of antibodies that mimic a healthy immune system.

VIG

VIG is an antibody-based product that is designed to treat smallpox vaccine-related complications. These complications range from localized adverse reactions to inflammation of the brain. VIG is stockpiled by governmental organizations as an adjunct to smallpox vaccine for two reasons: first, to treat complications in the case that a government mass vaccinates its citizens with smallpox vaccine; second, to be given to immuno-suppressed patients who cannot receive the vaccine in the event of a smallpox terrorist attack.

HBIG

HBIG is an antibody-based product that contains antibodies specific to hepatitis B, or HBV. HBV can cause lifelong infection, scarring of the liver, liver cancer, liver failure and death. Many patients with chronic HBV infection require a liver transplant. After liver transplant surgery, there is a high risk that these transplant patients will be reinfected with HBV, which destroys the transplanted liver. To prevent reinfection, these patients require life long treatment for HBV. HBIG is one of the treatments used to prevent reinfection of the transplanted liver.